Cancer
Cellular signaling, immune recognition, and the tumor microenvironment, studied to understand how cancers begin, progress, and respond to therapy.

MRK Foundation advances evidence-based research in advanced gene and cell therapy, working at the molecular and cellular level across cancer, autoimmunity, gut health, longevity, and AI-based discovery.
To advance evidence-based research at the molecular and cellular level, and to help translate that understanding into advanced therapies that can meaningfully improve care.
A future in which cancer, autoimmunity, and age-related disease are understood, and increasingly addressed, at the molecular and cellular level.
We believe meaningful progress in medicine begins with rigorous cellular science. We favor depth over breadth, question-driven inquiry over trend, and long-horizon research over short-term visibility. Every area we support is chosen because the underlying biology matters, and because a careful answer, even a partial one, moves the field forward.
Nine interconnected fields of clinical and laboratory research, spanning the heart, the brain, the nerves, the gut, and the immune system. Each is pursued as an advanced molecular and cellular question, and together they describe the systems we serve.
Cellular signaling, immune recognition, and the tumor microenvironment, studied to understand how cancers begin, progress, and respond to therapy.
How immune tolerance is built, maintained, and lost, and which cellular pathways can help restore balance in autoimmune disease.
The heart as a cellular system, studied through cardiomyocyte biology, vascular signaling, and the repair mechanisms that follow injury.
Neuronal and glial biology, neuroinflammation, and the cellular processes underlying cognitive decline and neurodegenerative disease.
Peripheral nerve integrity, myelin biology, and the neuromuscular junction, examined where signaling between nerve and muscle is lost or restored.
The microbiome, mucosal immunity, and the intestinal barrier, examined as regulators of both digestive and systemic health.
Cellular aging, senescence, and metabolic resilience, and the biology that sustains health across a longer human lifespan.
Stem cell biology, tissue repair, and regenerative strategies designed to work with the body's own repair systems.
Computational modeling and AI-guided analysis, used to interpret complex cellular data and inform the design of advanced therapies.

We describe our approach as a sequence, not because science is linear, but because each stage reinforces the next.
We begin with careful study of the biology, reading the literature, mapping the questions, and identifying where evidence is genuinely missing.
We support investigators pursuing rigorous, hypothesis-driven work in advanced gene and cell therapy, with an emphasis on reproducibility.
We connect scientists, clinicians, and institutions so that discoveries can travel across disciplines and be tested in wider contexts.
We back methods and technologies that expand what can be measured, modelled, and understood inside living systems.
We keep the person at the center, asking, at every stage, whether the science can lead to better detection, care, and quality of life.

Laboratory findings only matter when they reach the people waiting for them. Our work is oriented toward the clinic, where cellular science becomes care.
"Progress in medicine rarely arrives loudly. It comes from patient, disciplined work at the level of the cell, and from the willingness to support that work over many years, without shortcuts."
We believe research is a long conversation between science and the people it serves. Our role is to hold space for that conversation, quietly, credibly, and for as long as it takes.
The MRK Foundation
For research collaboration, academic inquiries, or general questions about the foundation, please reach out. We read every message.